Startup on the cheap

By Chris Tachibana Startup on the cheap A faded red Volkswagen dune buggy sails into the parking lot of a forgettable brown cinderblock building in Seattle with Johnny Stine at the wheel. Stine’s transportation and vision for his biotechnology lab are straight out of the 1970s, when Genentech started in a warehouse, and Bill Gates and Paul Allen created Microsoft on a shoestring. Now, Stine is trying to do the same with North Coast Biologics. Mos

Written byChris Tachibana
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A faded red Volkswagen dune buggy sails into the parking lot of a forgettable brown cinderblock building in Seattle with Johnny Stine at the wheel. Stine’s transportation and vision for his biotechnology lab are straight out of the 1970s, when Genentech started in a warehouse, and Bill Gates and Paul Allen created Microsoft on a shoestring. Now, Stine is trying to do the same with North Coast Biologics. Most companies need only a coffee pot and eager minds to get started, but Stine’s, which makes monoclonal antibodies, needs flow hoods, CO2 incubators and high-throughput robotics. To get these pricey items, he has taken a bargain-hunting, do-it-yourself approach that fits today’s new frugality.

In the cinderblock building’s aggressively unglamorous storage garage, which doubles as a cell culture room, water stains on the cement floor are paired with tidy patches in the ceiling above. The nearly 100 square-meter space is all bare-bones ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies